United Arab Emirates Influenza Treatment Market Size, Share & Trends Analysis Report By Product (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy) and By Country (U.S., Canada) Forecasts, 2026-2034

United Arab Emirates Influenza Treatment Market Insights

The United Arab Emirates influenza treatment market size was valued at USD 318.00 million in 2025 and is projected to grow from USD 345.03 million in 2026 to reach USD 662.67 million by 2034, growing at a CAGR of 8.50% during the forecast period 2026–2034.

The growth is driven by various factors, such as advancements in healthcare infrastructure, a rising prevalence of respiratory diseases, and increased government initiatives to enhance healthcare accessibility. The market’s expansion is further fueled by the growing adoption of antiviral drugs and the increasing role of hospitals and clinics in providing influenza treatment.

Segmentation Analysis

By Drug Type

Locally Acting Antiviral Agents dominate the drug type segment and are expected to grow at a CAGR of 4.3% over the forecast period. These drugs are gaining traction because they offer targeted treatment that minimizes adverse effects, making them a preferred option for physicians and patients. The rise in chronic conditions such as diabetes and hypertension, which increase susceptibility to influenza complications, drives demand for these treatments. Additionally, the UAE's pharmaceutical market is gradually shifting toward adopting innovative drugs tailored to local healthcare needs, creating favorable conditions for the growth of locally acting antivirals.

Request Customizationto receive a tailored report.

By End User

Hospitals and clinics continue to dominate the end-user segment of the UAE influenza treatment market, with an expected CAGR of 4.6%. The increasing availability of advanced healthcare facilities, supported by government investments, ensures that hospitals remain the primary location for influenza diagnosis and treatment. The UAE government’s initiatives to strengthen healthcare infrastructure, mainly through the Dubai Health Authority (DHA) and Abu Dhabi Health Services (SEHA), have contributed to a rise in hospital-based treatments. Additionally, the growing emphasis on specialized medical centers dealing with respiratory diseases has increased hospital visits for influenza treatment.

Speak to an Analystto discuss market opportunities.

United Arab Emirates Influenza Treatment Market Regional Insights

The market is characterized by significant regional disparities in healthcare access, technological advancement, and disease burden across the UAE. While the overall market is expanding, the growth pattern is influenced by key cities and healthcare policies aimed at improving access and treatment outcomes.

• Dubai is at the forefront of the UAE influenza treatment market, with its robust healthcare infrastructure and a high concentration of private and public hospitals. The city is home to leading medical centers, such as the American Hospital Dubai, which offers advanced treatment options. Dubai’s emphasis on medical tourism has also contributed to its role as a hub for healthcare services, attracting patients from across the region. The increasing number of expatriates and tourists further boosts the demand for influenza treatment, ensuring the city’s dominance in the market.
• Abu Dhabi plays a crucial role in the country’s healthcare landscape as the capital of the UAE. The city has made significant strides in establishing cutting-edge medical facilities, such as the Cleveland Clinic Abu Dhabi, which provides state-of-the-art influenza treatment services. With government investments in healthcare infrastructure and ongoing public health campaigns, Abu Dhabi’s market is expected to grow rapidly.
• Sharjah is witnessing growth in influenza treatment demand due to increasing healthcare facilities catering to the local population and expatriates. The rise in respiratory diseases and the city’s emphasis on improving healthcare services contribute to the growth of the influenza treatment market. Partnerships between private hospitals and international pharmaceutical companies are also supporting market expansion.
• Ajman, with its emerging healthcare sector, is seeing an increase in demand for influenza treatments, mainly as the city develops its medical infrastructure. The introduction of advanced clinics and treatment centers is helping improve access to antiviral medications, driving market growth. The government’s healthcare initiatives in Ajman further support the market's upward trajectory.
• Fujairah's healthcare sector, though smaller than Dubai or Abu Dhabi, has shown strong growth in recent years. The government’s efforts to upgrade medical facilities and provide accessible healthcare have contributed to the increased adoption of influenza treatments. Regional hospitals in Fujairah are equipped with modern antiviral treatments, ensuring the growth of the influenza treatment market in the region.

List of Key and Emerging Players in United Arab Emirates Influenza Treatment Market